Exp Ther Med . Kidney involvement in coronavirus-associated diseases (Review)

[tetano]

Exp Ther Med


. 2021 Apr;21(4):361.
doi: 10.3892/etm.2021.9792. Epub 2021 Feb 13.
Kidney involvement in coronavirus-associated diseases (Review)


Zhicai Feng ¹ , Yuqing Chen ² , Yuqin Wu ³ , Jianwen Wang ¹ , Hao Zhang ¹ , Wei Zhang ¹



Affiliations

• PMID: 33732334
• PMCID: PMC7903379
• DOI: 10.3892/etm.2021.9792

Abstract

Since 2003, coronaviruses have caused multiple global pandemic diseases, including severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS) and coronavirus disease 2019 (COVID-19). Clinical and autopsy findings suggest that the occurrence of kidney injury during infection may negatively affect the clinical outcomes of infected patients. The authoritative model predicts that outbreaks of other novel coronavirus pneumonias will continue to threaten human health in the future. The aim of the present systematic review was to summarize the basic knowledge of coronavirus, coronavirus infection-associated kidney injury and the corresponding therapies, in order to provide new insights for clinicians to better understand the kidney involvement of coronavirus so that more effective therapeutic strategies can be employed against coronavirus infection in the future.

Keywords: Middle East respiratory syndrome; coronavirus; coronavirus disease 2019; kidney injury; severe acute respiratory syndrome.